Trial Outcomes & Findings for Minimally Invasive or Conventional Edge-To-Edge Repair for Severe Mitral Regurgitation Due to Bileaflet Prolapse in Barlow's Disease: Does the Surgical Approach Have an Impact on the Long-term Results? (NCT NCT04002648)
NCT ID: NCT04002648
Last Updated: 2020-08-07
Results Overview
The cumulative incidence function (CIF) of cardiac death at 12 years, with noncardiac death as a competing risk
Recruitment status
COMPLETED
Target enrollment
208 participants
Primary outcome timeframe
12 years
Results posted on
2020-08-07
Participant Flow
Participant milestones
| Measure |
MT-Right
Right minithoracotomy: Incision of the right chest between 3rd and 4th or 4th and 5th intercostal space
|
Sternotomy
Sternotomy: Longitudinal resection of the sternum
|
|---|---|---|
|
Overall Study
STARTED
|
104
|
104
|
|
Overall Study
COMPLETED
|
102
|
104
|
|
Overall Study
NOT COMPLETED
|
2
|
0
|
Reasons for withdrawal
| Measure |
MT-Right
Right minithoracotomy: Incision of the right chest between 3rd and 4th or 4th and 5th intercostal space
|
Sternotomy
Sternotomy: Longitudinal resection of the sternum
|
|---|---|---|
|
Overall Study
Lost to Follow-up
|
2
|
0
|
Baseline Characteristics
2 patients lost to follow-up
Baseline characteristics by cohort
| Measure |
MT-Right
n=104 Participants
Right minithoracotomy: Incision of the right chest between 3rd and 4th or 4th and 5th intercostal space
|
Sternotomy
n=104 Participants
Sternotomy: Longitudinal resection of the sternum
|
Total
n=208 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
36 years
STANDARD_DEVIATION 8 • n=104 Participants
|
51 years
STANDARD_DEVIATION 13 • n=104 Participants
|
43.5 years
STANDARD_DEVIATION 10.5 • n=208 Participants
|
|
Sex: Female, Male
Female
|
68 Participants
n=102 Participants • 2 patients lost to follow-up
|
38 Participants
n=104 Participants • 2 patients lost to follow-up
|
106 Participants
n=206 Participants • 2 patients lost to follow-up
|
|
Sex: Female, Male
Male
|
34 Participants
n=102 Participants • 2 patients lost to follow-up
|
66 Participants
n=104 Participants • 2 patients lost to follow-up
|
100 Participants
n=206 Participants • 2 patients lost to follow-up
|
|
Region of Enrollment
Italy
|
102 participants
n=102 Participants • 2 patients lost to follow-up
|
104 participants
n=104 Participants • 2 patients lost to follow-up
|
206 participants
n=206 Participants • 2 patients lost to follow-up
|
PRIMARY outcome
Timeframe: 12 yearsThe cumulative incidence function (CIF) of cardiac death at 12 years, with noncardiac death as a competing risk
Outcome measures
| Measure |
MT-Right
n=102 Participants
Right minithoracotomy: Incision of the right chest between 3rd and 4th or 4th and 5th intercostal space
|
Sternotomy
n=104 Participants
Sternotomy: Longitudinal resection of the sternum
|
|---|---|---|
|
Cardiac Death
|
3.9 percentage of participants with event
Interval 0.6 to 13.3
|
3.8 percentage of participants with event
Interval 1.3 to 8.8
|
PRIMARY outcome
Timeframe: 12 yearsThe cumulative incidence function (CIF) of recurrent mitral regurgitation (MR) \>\_ 3+, with death as the competing risk
Outcome measures
| Measure |
MT-Right
n=102 Participants
Right minithoracotomy: Incision of the right chest between 3rd and 4th or 4th and 5th intercostal space
|
Sternotomy
n=104 Participants
Sternotomy: Longitudinal resection of the sternum
|
|---|---|---|
|
Severe MR
|
5.8 percentage of participants with event
Interval 1.8 to 13.4
|
11.4 percentage of participants with event
Interval 5.9 to 18.8
|
Adverse Events
MT-Right
Serious events: 11 serious events
Other events: 0 other events
Deaths: 0 deaths
Sternotomy
Serious events: 10 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
| Measure |
MT-Right
n=102 participants at risk
Right minithoracotomy: Incision of the right chest between 3rd and 4th or 4th and 5th intercostal space
|
Sternotomy
n=104 participants at risk
Sternotomy: Longitudinal resection of the sternum
|
|---|---|---|
|
Surgical and medical procedures
Reoperation
|
10.8%
11/102 • Number of events 11
|
9.6%
10/104 • Number of events 10
|
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place